Newsletters and Deep Dive digital magazine
Outdated or offensive terminology can reinforce barriers to clinical trial participation and accessible healthcare.
Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in distributed ledger technology (DLT) on the rise, then it would appear that momentum is b
Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking for a wider view when looking for insights to inform their branding?
Helping someone live with a condition as complex as MS can be fraught with challenges.
New data point to impressive efficacy in advanced EGFR-mutated non-small cell lung cancer.
An inside guide to unlocking clinical research in the UK